Skip to Main Content

Advertisement

Skip Nav Destination

Phase II Study of Pembrolizumab in Combination with Doxorubicin in Metastatic and Unresectable Soft-Tissue Sarcoma

Clin Cancer Res (2021) 27 (23): 6424–6431.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Laurie Graves
  • William R. Jeck
  • Juneko E. Grilley-Olson
Current Treatment Options in Oncology (2023)
  • Pampina Pilavaki
  • Myrofora Panagi
  • Samia Arifi
  • Robin L. Jones
  • Triantafyllos Stylianopoulos
  • Anastasia Constantinidou
Frontiers in Oncology (2023) 12
  • Zhichao Tian
  • Shuping Dong
  • Yang Yang
  • Shilei Gao
  • Yonghao Yang
  • Jinpo Yang
  • Peng Zhang
  • Xin Wang
  • Weitao Yao
BMC Cancer (2022) 22 (1)
  • Zhichao Tian
  • Weitao Yao
Frontiers in Immunology (2022) 13
  • Lauren B. Banks
  • Sandra P. D’Angelo
Journal of the National Comprehensive Cancer Network (2022) 20 (7): 834.
  • Meghan M. Lynch
  • Borislav A. Alexiev
  • Brett A. Schroeder
  • Seth M. Pollack
Current Treatment Options in Oncology (2022) 23 (12): 1861.
  • Zhichao Tian
  • Shuping Dong
  • Wenli Zuo
  • Po Li
  • Fan Zhang
  • Shilei Gao
  • Yonghao Yang
  • Chao Li
  • Peng Zhang
  • Xin Wang
  • Jiaqiang Wang
  • Weitao Yao
Frontiers in Pharmacology (2022) 13
  • Cristiam Moreno Tellez
  • Yan Leyfman
  • Sandra P. D'Angelo
  • Breelyn A. Wilky
  • Armelle Dufresne
Surgical Oncology Clinics of North America (2022) 31 (3): 381.
Close Modal

or Create an Account

Close Modal
Close Modal